RGD modified polymers: Biomaterials for stimulated cell adhesion and beyond

Biomaterials

Volumn 24, Issue 24, 2003, Pages 4385-4415

  Hersel, Ulrich ^a   Dahmen, Claudia ^a   Kessler, Horst ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell attachment; Cell behavior; Integrin; Polymer modification; Review; RGD peptide

Indexed keywords

ADHESION; AMINO ACIDS; BIOMATERIALS; CELLS; MOLECULES; SURFACE PROPERTIES;

CELL ADHESION;

BIOPOLYMERS;

ARGINYLGLYCYLASPARTIC ACID; BIOMATERIAL; CELL MEMBRANE PROTEIN; COPOLYMER; FIBRONECTIN; INTEGRIN; POLYMER; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; BINDING AFFINITY; BONE REGENERATION; CELL ACTIVATION; CELL ADHESION; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL SURFACE; CELLULAR DISTRIBUTION; CROSS LINKING; DENSITY; EVALUATION; HUMAN; IN VITRO STUDY; MATERIAL COATING; MOLECULAR RECOGNITION; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN LOCALIZATION; PROTEIN MOTIF; REVIEW; SURFACE PROPERTY; TISSUE REPAIR;

EID: 0041559949     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00343-0     Document Type: Article

References (372)

1. Epple M., Rueger J.M. Festkörperchemie und Chirurgie. Nachr Chem Tech Lab. 47:1999;1405-1410.
2. Thull R. Surface functionalization of materials to initiate auto-biocompatibilization in vivo. Materialwiss Werkst. 32:2001;949-952.
3. Sakiyama-Elbert S.E., Hubbell J.A. Functional biomaterials. design of novel biomaterials Annu Rev Mater Res. 31:2001;183-201.
4. Langer R. Biomaterials in drug delivery and tissue engineering. one laboratory's experience Acc Chem Res. 33:2000;94-101.
5. Lebaron R.G., Athanasiou K.A. Extracellular matrix cell adhesion peptides. functional applications in orthopedic materials Tissue Eng. 6:2000;85-103.
6. Hubbell J.A. Bioactive biomaterials. Curr Opin Biotechnol. 10:1999;123-129.
7. Shakesheff K.M., Cannizzaro S.M., Langer R. Creating biomimetic micro-environments with synthetic polymer- peptide hybrid molecules. J Biomat Sci Polym Ed. 9:1998;507-518.
8. Elbert D.L., Hubbell J.A. Surface treatments of polymers for biocompatibility. Annu Rev Mater Sci. 26:1996;365-394.
9. Drumheller P.D., Herbert C.B., Hubbell J.A. Bioactive peptides and surface design. Bioprocess Technol. 23:1996;273-310.
10. Hubbell J.A. Biomaterials in tissue engineering. Bio/Technology. 13:1995;565-576.
11. Ikada Y. Surface modification of polymers for medical applications. Biomaterials. 15:1994;725-736.
12. Pierschbacher M.D., Polarek J.W., Craig W.S., Tschopp J.F., Sipes N.J., Harper J.R. Manipulation of cellular interactions with biomaterials toward a therapeutic outcome. a perspective J Cell Biochem. 56:1994;150-154.
13. Li J.M., Menconi M.J., Wheeler H.B., Rohrer M.J., Klassen V.A., Ansell J.E., Appel M.C. Precoating expanded polytetrafluoroethylene grafts alters production of endothelial cell-derived thrombomodulators. J Vasc Surg. 15:1992;1010-1017.
14. Miyata T., Conte M.S., Trudell L.A., Mason D., Whittemore A.D., Birinyi L.K. Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts. J Surg Res. 50:1991;485-493.
15. Vohra R., Thomson G.J., Carr H.M., Sharma H., Walker M.G. Comparison of different vascular prostheses and matrices in relation to endothelial seeding. Br J Surg. 78:1991;417-420.
16. Thomson G.J., Vohra R.K., Carr M.H., Walker M.G. Adult human endothelial cell seeding using expanded polytetrafluoroethylene vascular grafts. a comparison of four substrates Surgery. 109:1991;20-27.
17. Kaehler J., Zilla P., Fasol R., Deutsch M., Kadletz M. Precoating substrate and surface configuration determine adherence and spreading of seeded endothelial cells on polytetrafluoroethylene grafts. J Vasc Surg. 9:1989;535-541.
18. Sentissi J.M., Ramberg K., O'Donnell T.F. Jr., Connolly R.J., Callow A.D. The effect of flow on vascular endothelial cells grown in tissue culture on polytetrafluoroethylene grafts. Surgery. 99:1986;337-343.
19. Seeger J.M., Klingman N. Improved endothelial cell seeding with cultured cells and fibronectin-coated grafts. J Surg Res. 38:1985;641-647.
20. Weiβ N., Klee D., Höcker H. Konzept zur bioaktiven Ausrüstung von Metallimplantatoberfächen. Biomaterialien. 2:2001;81-86.
21. Elbert D.L., Hubbell J.A. Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. Biomacromolecules. 2:2001;430-441.
22. Fields G.B., Lauer J.L., Dori Y., Forns P., Yu Y-.C., Tirrell M. Proteinlike molecular architecture. biomaterial applications for inducing cellular receptor binding and signal transduction Biopolymers. 47:1998;143-151.
23. Rouhi A.M. Contemporary biomaterials. Chem Eng News. 77:1999;51-59.
24. Lhoest J.B., Detrait E., van den Bosch de Aguilar P., Bertrand P. Fibronectin adsorption, conformation, and orientation on polystyrene substrates studied by radiolabeling, XPS, and ToF SIMS. J Biomed Mater Res. 41:1998;95-103.
25. Hlady V.V., Buijs J. Protein adsorption on solid surfaces. Curr Opin Biotechnol. 7:1996;72-77.
26. Altankov G., Grinnell F., Groth T. Studies on the biocompatibility of materials. fibroblast reorganization of substratum-bound fibronectin on surfaces varying in wettability J Biomed Mater Res. 30:1996;385-391.
27. Pettit D.K., Hoffman A.S., Horbett T.A. Correlation between corneal epithelial cell outgrowth and monoclonal antibody binding to the cell binding domain of adsorbed fibronectin. J Biomed Mater Res. 28:1994;685-691.
28. Underwood P.A., Steele J.G., Dalton B.A. Effects of polystyrene surface chemistry on the biological activity of solid phase fibronectin and vitronectin, analysed with monoclonal antibodies. J Cell Sci. 104:1993;793-803.
29. Iuliano D.J., Saavedra S.S., Truskey G.A. Effect of the conformation and orientation of adsorbed fibronectin on endothelial cell spreading and the strength of adhesion. J Biomed Mater Res. 27:1993;1103-1113.
30. Lewandowska K., Pergament E., Sukenik C.N., Culp L.A. Cell-type-specific adhesion mechanisms mediated by fibronectin adsorbed to chemically derivatized substrata. J Biomed Mater Res. 26:1992;1343-1363.
31. Horbett T.A., Lew K.R. Residence time effects on monoclonal antibody binding to adsorbed fibrinogen. J Biomater Sci Polym Ed. 6:1994;15-33.
32. Ito Y., Kajihara M., Imanishi Y. Materials for enhancing cell adhesion by immobilization of cell-adhesive peptide. J Biomed Mater Res. 25:1991;1325-1337.
33. Boxus T., Touillaux R., Dive G., Marchand-Brynaert J. Synthesis and evaluation of RGD peptidomimetics aimed at surface bioderivatization of polymer substrates. Bioorg Med Chem. 6:1998;1577-1595.
34. Neff J.A., Caldwell K.D., Tresco P.A. A novel method for surface modification to promote cell attachment to hydrophobic substrates. J Biomed Mater Res. 40:1998;511-519.
35. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 12:1996;697-715.
36. Massia S.P., Hubbell J.A. An RGD spacing of 440. nm is sufficient for integrin αvβ3-mediated fibroblast spreading and 140 nm for focal contact fiber formation J Cell Biol. 114:1991;1089-1100.
37. Aumailley M., Gurrath M., Müller G., Calvete J., Timpl R., Kessler H. Arg-Gly Asp constrained within cyclic pentapeptides, strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. 291:1991;50-54.
38. Gurrath M., Müller G., Kessler H., Aumailley M., Timpl R. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides. Eur J Biochem. 210:1992;911-921.
39. Ivanov B., Grzesik W., Robey F.A. Synthesis and use of a new bromoacetyl-derivatized heterotrifunctional amino acid for conjugation of cyclic RGD-containing peptides derived from human bone sialoprotein. Bioconjug Chem. 6:1995;269-277.
40. Sulyok G.A.G., Gibson C., Goodman S.L., Hölzemann G., Wiesner M., Kessler H. Solid-phase synthesis of a nonpeptide RGD mimetic library. New selective αvβ3 integrin antagonists J Med Chem. 44:2001;1938-1950.
41. Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion. RGD and integrins Science. 238:1987;491-497.
42. Albelda S.M., Buck C.A. Integrins and other cell adhesion molecules. FASEB J. 4:1990;2868-2880.
43. Travis J. Biotech gets a grip on cell adhesion. Science. 260:1993;906-908.
44. van der Flier A., Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 305:2001;285-298.
45. Plow E.F., Haas T.A., Zhang L., Loftus J., Smith J.W. Ligand binding to integrins. J Biol Chem. 275:2000;21785-21788.
46. Pierschbacher M.D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature. 309:1984;30-33.
47. Pfaff M. Recognition sites of RGD-dependent integrins. Eble J.A. Integrin-Ligand Interaction. 1997;101-121 Springer-Verlag, Heidelberg.
48. Hynes R.O. Integrins. versatility, modulation, and signaling in cell adhesion Cell. 69:1992;11-25.
49. Zamir E., Geiger B. Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci. 114:2001;3583-3590.
50. Geiger B., Bershadsky A. Assembly and mechanosensory function of focal contacts. Curr Opin Cell Biol. 13:2001;584-592.
51. Petit V., Thiery J.P. Focal adhesions. structure and dynamics Biol Cell. 92:2000;477-494.
52. Pande G. The role of membrane lipids in regulation of integrin functions. Curr Opin Cell Biol. 12:2000;569-574.
53. Horwitz A.R., Parsons J.T. Cell migration-movin' on. Science. 286:1999;1102-1103.
54. Gottschalk K-.E., Adams P.D., Brunger A.T., Kessler H. Transmembrane signal-transduction of the αIIββ3 integrin. Protein Sci. 11:2002;1800-1812.
55. Gottschalk K-.E., Günther R., Kessler H. A three state mechanism of integrin activation and signal transduction of integrin αvβ3. ChemBioChem. 3:2002;470-473.
56. Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L., Joachimiak A., Goodman S.L., Arnaout M.A. Crystal structure of the extracellular segment of integrin αvβ3. Science. 294:2001;339-345.
57. Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., Arnaout M.A. Crystal structure of the extracellular segment of integrin αvβ3 in complex with an Arg-Gly Asp ligand. Science. 296:2002;151-155.
58. Arnaout M.A., Goodman S.L., Xiong J-.P. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol. 14:2002;641-651.
59. Gottschalk K-.E., Kessler H. The structures of integrins and integrin-ligand complexes. implications for drug design and signal transduction Angew Chem Int Ed. 41:2002;3674-3767.
60. Boudreau N.J., Jones P.L. Extracellular matrix and integrin signalling. the shape of things to come Biochem J. 339:1999;481-488.
61. Schwartz M.A. Integrin signaling revisited. Trends Cell Biol. 11:2001;466-470.
62. Giancotti F.G. Complexity and specificity of integrin signalling. Nat Cell Biol. 2:1999;E13-14.
63. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science. 276:1997;1425-1428.
64. Damsky C.H. Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone. 25:1999;95-96.
65. Ruoslahti E., Pierschbacher M.D., Woods V.L. The α5β integrin in tumor suppression. Bull Inst Pasteur. 92:1994;242-247.
66. Stupack D.G., Puente X.S., Boutsaboualoy S., Storgard C.M., Cheresh D.A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol. 155:2001;459-470.
67. Grano M., Zigrino P., Colucci S., Zambonin G., Trusolino L., Serra M., Baldini N., Teti A., Marchisio P.C., Zallone A.Z. Adhesion properties and integrin expression of cultured human osteoclast-like cells. Exp Cell Res. 212:1994;209-218.
68. Noiri E., Gailit J., Sheth D., Magazine H., Gurrath M., Muller G., Kessler H., Goligorsky M.S. Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney Int. 46:1994;1050-1058.
69. Stromblad S., Becker J.C., Yebra M., Brooks P.C., Cheresh D.A. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J Clin Invest. 98:1996;426-433.
70. Cheng S., Craig W.S., Mullen D., Tschopp J.F., Dixon D., Pierschbacher M.D. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin αIIbβ3 antagonists. J Med Chem. 37:1994;1-8.
71. Haubner R., Gratias R., Diefenbach B., Goodman S.L., Jonczyk A., Kessler H. Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin αvβ3 antagonists. J Am Chem Soc. 118:1996;7461-7472.
72. Buckley C.D., Pilling D., Henriquez N.V., Parsonage G., Threlfall K., Scheel-Toellner D., Simmons D.L., Albar A.N., Lord J.M., Salmon M. RGD peptides induce apoptosis by direct caspase-3 activation. Nature. 397:1999;534-539.
73. Hynes R.O. A reevaluation of integrins as regulators of angiogenesis. Nat Med. 8:2002;918-921.
74. Katz B.Z., Zamir E., Bershadsky A., Kam Z., Yamada K.M., Geiger B. Physical state of the extracellular matrix regulates the structure and molecular composition of cell-matrix adhesions. Mol Biol Cell. 11:2000;1047-1060.
75. Pelham R.J. Jr., Wang Y.L. Cell locomotion and focal adhesions are regulated by the mechanical properties of the substrate. Biol Bull. 194:1998;348-350.
76. Choquet D., Felsenfeld D.P., Sheetz M.P. Extracellular matrix rigidity causes strengthening of integrin-cytoskeleton linkages. Cell. 88:1997;39-48.
77. Grinnell F. Focal adhesion sites and the removal of substratum-bound fibronectin. J Cell Biol. 103:1986;2697-2706.
78. Gaebel K., Feuerstein I.A. Platelets process adsorbed protein. a morphological study Biomaterials. 12:1991;597-602.
79. Castel S., Pagan R., Mitjans F., Piulats J., Goodman S., Jonczyk A., Huber F., Vilaro S., Reina M. RGD peptides and monoclonal antibodies, antagonists of αvβ3-integrin, enter the cells by independent endocytic pathways. Lab Invest. 81:2001;1615-1626.
80. Memmo L.M., McKeown-Longo P. The αvβ5 integrin functions as an endocytic receptor for vitronectin. J Cell Sci. 111:1998;425-433.
81. Walluscheck K.P., Steinhoff G., Kelm S., Haverich A. Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur J Vasc Endovasc. 12:1996;321-330.
82. Varani J., Inman D.R., Fligiel S.E., Hillegas W.J. Use of recombinant and synthetic peptides as attachment factors for cells on microcarriers. Cytotechnology. 13:1993;89-98.
83. Quirk R.A., Chan W.C., Davies M.C., Tendler S.J.B., Shakesheff K.M. Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). Biomaterials. 22:2001;865-872.
84. Yang X.B., Roach H.I., Clarke N.M., Howdle S.M., Quirk R., Shakesheff K.M., Oreffo R.O. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone. 29:2001;523-531.
85. Neff J.A., Tresco P.A., Caldwell K.D. Surface modification for controlled studies of cell-ligand interactions. Biomaterials. 20:1999;2377-2393.
86. Hirano Y., Okuno M., Hayashi T., Goto K., Nakajima A. Cell-attachment activities of surface immobilized oligopeptides RGD, RGDS, RGDV, RGDT, and YIGSR toward five cell lines. J Biomater Sci Polym Ed. 4:1993;235-243.
87. Stile R.A., Healy K.E. Thermo-responsive peptide-modified hydrogels for tissue regeneration. Biomacromolecules. 2:2001;185-194.
88. Anderheiden D., Brenner O., Klee D., Kaufmann R., Richter H.A., Mittermayer C., Hocker H. Development and characterization of a biocompatible OH-modified copolymer based on polyurethane. Angew Makromol Chem. 185:1991;109-127.
89. Moghaddam M.J., Matsuda T. Molecular design of 3-dimensional artificial extracellular matrix. photosensitive polymers containing cell adhesive peptide J Polym Sci Pol Chem. 31:1993;1589-1597.
90. Brandley B.K., Schnaar R.L. Covalent attachment of an Arg-Gly Asp sequence peptide to derivatizable polyacrylamide surfaces. support of fibroblast adhesion and long-term growth Anal Biochem. 172:1988;270-278.
91. Schnaar R.L., Langer B.G., Brandley B.K. Reversible covalent immobilization of ligands and proteins on polyacrylamide gels. Anal Biochem. 151:1985;268-281.
92. Banerjee P., Irvine D.J., Mayes A.M., Griffith L.G. Polymer latexes for cell-resistant and cell-interactive surface. J Biomed Mater Res. 50:2000;331-339.
93. Cook A.D., Hrkach J.S., Gao N.N., Johnson I.M., Pajvani U.B., Cannizzaro S.M., Langer R. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J Biomed Mater Res. 35:1997;513-523.
94. Barrera D.A., Zylstra E., Lansbury P.T., Langer R. Synthesis and RGD peptide modification of a new biodegradable copolymer - poly(lactic acid-co-lysine). J Am Chem Soc. 115:1993;11010-11011.
95. Barrera D.A., Zylstra E., Lansbury P.T., Langer R. Copolymerization and degradation of poly(lactic acid co-lysine). Macromolecules. 28:1995;425-432.
96. Yamaoka T., Hotta Y., Kobayashi K., Kimura Y. Synthesis and properties of malic acid-containing functional polymers. Int J Biol Macromol. 25:1999;265-271.
97. Jo S., Engel P.S., Mikos A.G. Synthesis of poly(ethylene glycol)-tethered poly(propylene fumarate) and its modification with GRGD peptide. Polymer. 41:2000;7595-7604.
98. Shin H., Jo S., Mikos A.G. Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly(ethylene glycol) fumarate] hydrogels modified with Arg-Gly Asp peptides and a poly(ethylene glycol) spacer. J Biomed Mater Res. 61:2002;169-179.
99. Hrkach J.S., Ou J., Lotan N., Langer R. Synthesis of poly(L-lactic acid-co-L-lysine) graft-copolymers. Macromolecules. 28:1995;4736-4739.
100. Ho S.P., Britton H.O. Arg-Gly Asp eptides in polyurethanes - design, synthesis, and characterization. Adv Mater. 6:1994;130-132.
101. Drumheller P.D., Hubbell J.A. Polymer networks with grafted cell adhesion peptides for highly biospecific cell adhesive substrates. Anal Biochem. 222:1994;380-388.
102. Han D.K., Hubbell J.A. Lactide-based poly(ethylene glycol) polymer networks for scaffolds in tissue engineering. Macromolecules. 29:1996;5233-5235.
103. Bearinger J.P., Castner D.G., Healy K.E. Biomolecular modification of p(AAm-co-EG/AA) IPNs supports osteoblast adhesion and phenotypic exprssion. J Biomater Sci Polym Ed. 9:1998;629-652.
104. Breuers W., Klee D., Hocker H., Mittermayer C. Immobilization of a fibronectin fragment at the surface of a polyetherurethane film. J Mater Sci: Mater Med. 2:1991;106-109.
105. Kugo K., Okuno M., Masuda K., Nishino J., Masuda H., Iwatsuki M. Fibroblast attachment to Arg-Gly Asp peptide-immobilized poly(γ-methyl L-glutamate). J Biomater Sci Polym Ed. 5:1994;325-337.
106. Tong Y.W., Shoichet M.S. Peptide surface modification of poly(tetrafluoroethylene-co- hexafluoropropylene) enhances its interaction with central nervous system neurons. J Biomed Mater Res. 42:1998;85-95.
107. Porte-Durrieu M.C., Labrugere C., Villars F., Lefebvre F., Dutoya S., Guette A., Bordenave L., Baquey C. Development of RGD peptides grafted onto silica surfaces. XPS characterization and human endothelial cell interactions J Biomed Mater Res. 46:1999;368-375.
108. Lin H.B., Zhao Z.C., Garciaecheverria C., Rich D.H., Cooper S.L. Synthesis of a novel polyurethane copolymer containing covalently attached RGD peptide. J Biomater Sci Polym Ed. 3:1992;217-227.
109. Lin H.B., Sun W., Mosher D.F., Garciaecheverria C., Schaufelberger K., Lelkes P.I., Cooper S.L. Synthesis, surface, and cell-adhesion properties of polyurethanes containing covalently grafted RGD-peptides. J Biomed Mater Res. 28:1994;329-342.
110. Marchand-Brynaert J. Surface modifications and reactivity assays of polymer films and membranes by selective wet chemistry. Recent Res Polym Sci. 2:1998;335-361.
111. Marchand-Brynaert J., Detrait E., Noiset O., Boxus T., Schneider Y.J., Remacle C. Biological evaluation of RGD peptidomimetics, designed for the covalent derivatization of cell culture substrata, as potential promotors of cellular adhesion. Biomaterials. 20:1999;1773-1782.
112. Carlisle E.S., Mariappan M.R., Nelson K.D., Thomes B.E., Timmons R.B., Constantinescu A., Eberhart R.C., Bankey P.E. Enhancing hepatocyte adhesion by pulsed plasma deposition and polyethylene glycol coupling. Tissue Eng. 6:2000;45-52.
113. Lateef S.S., Boateng S., Hartman T.J., Crot C.A., Russell B., Hanley L. GRGDSP peptide-bound silicone membranes withstand mechanical flexing in vitro and display enhanced fibroblast adhesion. Biomaterials. 23:2002;3159-3168.
114. Harrison D., Johnson R., Tucci M., Puckett A., Tsao A., Hughes J., Benghuzzi H. Interaction of cells with UHMWPE impregnated with the bioactive peptides RGD, RGE or Poly L-lysine. Biomed Sci Instrum. 34:1997;41-46.
115. McConachie A., Newman D., Tucci M., Puckett A., Tsao A., Hughes J., Benghuzzi H. The effect on bioadhesive polymers either freely in solution or covalently attached to a support on human macrophages. Biomed Sci Instrum. 35:1999;45-50.
116. Healy KE, Tsai D, Kim JE. Osteogenic cell attachment to degradable polymers. Mater Res Soc Symp Proc 1992; 252: (Tissue-Inducing Biomaterials) 109-14.
117. Johnson R., Harrison D., Tucci M., Tsao A., Lemos M., Puckett A., Hughes J.L., Benghuzzi H. Fibrous capsule formation in response to ultrahigh molecular weight polyethylene treated with peptides that influence adhesion. Biomed Sci Instrum. 34:1997;47-52.
118. Kobayashi H., Ikada Y. Corneal cell adhesion and proliferation on hydrogel sheets bound with cell-adhesive proteins. Curr Eye Res. 10:1991;899-908.
119. Dettin M., Conconi M.T., Gambaretto R., Pasquato A., Folin M., Bello C.D., Parnigotto P.P. Novel osteoblast-adhesive peptides for dental/orthopedic biomaterials. J Biomed Mater Res. 60:2002;466-471.
120. Craig W.S., Cheng S., Mullen D.G., Blevitt J., Pierschbacher M.D. Concept and progress in the development of RGD-containing peptide pharmaceuticals. Biopolymers. 37:1995;157-175.
121. Olivieri M.P., Tweden K.S. Human serum albumin and fibrinogen interactions with an adsorbed RGD-containing peptide. J Biomed Mater Res. 46:1999;355-359.
122. Carpino L.A., Shroff H., Triolo S.A., Mansour E.M.E., Wenschuh H., Albericio F. The 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl group (Pbf) as arginine side-chain protectant. Tetrahedron Lett. 34:1993;7829-7832.
123. King D.S., Fields C.G., Fields G.B. A cleavage method which minimizes side reactions following Fmoc solid-phase peptide-synthesis. Int J Pept Prot Res. 36:1990;255-266.
124. Pearson D.A., Blanchette M., Baker M.L., Guindon C.A. Trialkylsilanes as scavengers for the trifluoroacetic acid deblocking of protecting groups in peptide synthesis. Tetrahedron Lett. 30:1989;2739-2742.
125. Jo S., Mikos A.G. Modification of poly(ethylene glycol)-tethered poly(propylene-co-fumarate) with RGD peptide. Polym Prep. 40:1999;183-184.
126. Kao W.J., Hubbell J.A. Murine macrophage behavior on peptide-grafted polyethyleneglycol-containing networks. Biotechnol Bioeng. 59:1998;2-9.
127. Drumheller P.D., Elbert D.L., Hubbell J.A. Multifunctional poly(ethylene glycol) semiinterpenetrating polymer networks as highly selective adhesive substrates for bioadhesive peptide grafting. Biotechnol Bioeng. 43:1994;772-780.
128. Besselink G.A.J., Beugeling T., Bantjes A. N-hydroxysuccinimide-activated glycine-sepharose - hydrolysis of activated groups and coupling of amino-compounds. Appl Biochem Biotechnol. 43:1993;227-246.
129. Morpurgo M., Bayer E.A., Wilchek M. N-hydroxysuccinimide carbonates and carbamates are useful reactive reagents for coupling ligands to lysines on proteins. J Biochem Biophys Methods. 38:1999;17-28.
130. Hern D.L., Hubbell J.A. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res. 39:1998;266-276.
131. Dai W., Belt J., Saltzman W.M. Cell-binding peptides conjugated to poly(ethylene glycol) promote neural cell aggregation. Bio/Technology. 12:1994;797-801.
132. Beer J.H., Springer K.T., Coller B.S. Immobilized Arg-Gly Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood. 79:1992;117-128.
133. Kondoh A., Makino K., Matsuda T. 2-Dimensional artificial extracellular-matrix - boadhesive peptide-immobilized surface design. J Appl Polym Sci. 47:1993;1983-1988.
134. Kim M.R., Jeong J.H., Park T.G. Swelling induced detachment of chondrocytes using RGD-modified Poly(N-isopropylacrylamide) hydrogel beads. Biotechnol Prog. 18:2002;495-500.
135. Massia S.P., Hubbell J.A. Human endothelial cell interactions with surface-coupled adhesion peptides on a nonadhesive glass substrate and two polymeric biomaterials. J Biomed Mater Res. 25:1991;223-242.
136. Nilsson K., Mosbach K. Immobilization of ligands with organic sulfonyl chlorides. Methods Enzymol. 104:1984;56-69.
137. Massia S.P., Hubbell J.A. Covalently attached GRGD on polymer surfaces promotes biospecific adhesion of mammalian cells. Ann NY Acad Sci. 589:1990;261-270.
138. Jo S., Shin H., Mikos A.G. Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules. 2:2001;255-261.
139. Woerly S., Laroche G., Marchand R., Pato J., Subr V., Ulbrich K. Intracerebral implantation of hydrogel-coupled adhesion peptides. tissue reaction J Neural Transplant Plast. 5:1995;245-255.
140. Li J.T., Carlsson J., Lin J.N., Caldwell K.D. Chemical modification of surface active poly(ethylene oxide)-poly(propylene oxide) triblock copolymers. Bioconjug Chem. 7:1996;592-599.
141. Sanchez M., Deffieux A., Bordenave L., Borquey C., Fontanille M. Synthesis of hemocompatible materials. Part 1. Surface modification of polyurethanes based on Poly(chloroalkylvinylether)s by RGD fragments Clin Mater. 15:1994;253-258.
142. Tam J.P., Yu Q., Miao Z. Orthogonal ligation strategies for peptide and protein. Biopolymers. 51:1999;311-332.
143. Tuchscherer G. Template assembled synthetic proteins. condensation of a multifunktional peptide to a topological template via chemoselective ligation Tetrahedron Lett. 34:1993;8410-8422.
144. Wahl F., Mutter M. Analogues of oxytocin with an oxime bridge using chemoselectively addressable building blocks. Tetrahedron Lett. 37:1996;6861-6864.
145. Scheibler L., Dumy P., Boncheva M., Leufgen K., Mathieu H-.J., Mutter M., Vogel H. Functional molecular thin films. topological templates for the chemoselective ligation of antigenic peptides to self-assembled monolayers Angew Chem Int Ed. 38:1999;696-699.
146. Thumshirn G, Hersel U, Kessler H. Multimeric cyclic RGD peptides for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation. Chem Eur J, submitted for publication.
147. Kantlehner M., Schaffner P., Finsinger D., Meyer J., Jonczyk A., Diefenbach B., Nies B., Hölzemann G., Goodman S.L., Kessler H. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. ChemBioChem. 1:2000;107-114.
148. Schaffner P., Meyer J., Dard M., Wenz R., Nies B., Verrier S., Kessler H., Kantlehner M. Induced tissue integration of bone implants by coating with bone selective RGD-peptides in vitro and in vivo studies. J Mater Sci: Mater Med. 10:1999;837-839.
149. Mammen M., Choi S-.K., Whitesides G.M. Polyvalent interactions in biological systems. implications for design and use of multivalent ligands and inhibitors Angew Chem Int Ed. 37:1998;2755-2794.
150. Herbert C.B., McLernon T.L., Hypolite C.L., Adams D.N., Pikus L., Huang C.C., Fields G.B., Letourneau P.C., Distefano M.D., Hu W.S. Micropatterning gradients and controlling surface densities of photoactivatable biomolecules on self-assembled monolayers of oligo(ethylene glycol) alkanethiolates. Chem Biol. 4:1997;731-737.
151. Lin Y.S., Wang S.S., Chung T.W., Wang Y.H., Chiou S.H., Hsu J.J., Chou N.K., Hsieh K.H., Chu S.H. Growth of endothelial cells on different concentrations of Gly Arg-Gly Asp photochemically grafted in polyethylene glycol modified polyurethane. Artif Organs. 25:2001;617-621.
152. Sugawara T., Matsuda T. Photochemical surface derivatization of a peptide containing Arg-Gly Asp (RGD). J Biomed Mater Res. 29:1995;1047-1052.
153. Mizutani M., Arnold S.C., Matsuda T. Liquid, phenylazide-end-capped copolymers of epsilon-caprolactone and trimethylene carbonate. preparation, photocuring characteristics, and surface layering Biomacromolecules. 3:2002;668-675.
154. Lin H.B., Garciaecheverria C., Asakura S., Sun W., Mosher D.F., Cooper S.L. Endothelial-cell adhesion on polyurethanes containing covalently attached RGD-peptides. Biomaterials. 13:1992;905-914.
155. Lin H.B., Lewis K.B., Leachscampavia D., Ratner B.D., Cooper S.L. Surface-properties of RGD-peptide grafted polyurethane block copolymers - variable take-off angle and cold-stage ESCA studies. J Biomater Sci Polym Ed. 4:1993;183-198.
156. Healy K.E., Rezania A., Stile R.A. Designing biomaterials to direct biological responses. Ann NY Acad Sci. 875:1999;24-35.
157. Brandley B.K., Schnaar R.L. Tumor cell haptotaxis on covalently immobilized linear and exponential gradients of a cell adhesion peptide. Dev Biol. 135:1989;74-86.
158. Salacinski P.R., McLean C., Sykes J.E., Clement-Jones V.V., Lowry P.J. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α,6α-diphenyl glycoluril (Iodogen). Anal Biochem. 117:1981;136-146.
159. Oku N., Koike C., Tokudome Y., Okada S., Nishikawa N., Tsukada H., Kiso M., Hasegawa A., Fujii H., Murata J., Saiki I. Application of liposomes for cancer metastasis. Adv Drug Del Rev. 24:1997;215-223.
160. Snyder S.L., Sobocinski P.Z. An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem. 64:1975;284-288.
161. Parniak M.A., Lange G., Viswanatha T. Quantitative determination of monosubstituted guanidines. a comparative study of different procedures J Biochem Biophys Methods. 7:1983;267-276.
162. Irvine D.J., Mayes A.M., Griffith L.G. Nanoscale clustering of RGD peptides at surfaces using comb polymers - 1. Synthesis and characterization of comb thin films. Biomacromolecules. 2:2001;85-94.
163. Kantlehner M. Beschichtung künstlicher Oberflächen mit hochaktiven und für das alpavbeta3-Integrin selektiven RGD-Peptiden zur Stimulation der integrinvermittelten Zelladhäsion. Dissertation, Technische Universität München, 2000.
164. Irvine D.J., Ruzette A-.V.G., Mayes A.M., Griffith L.G. Nanoscale clustering of RGD peptides at surfaces using comb polymers - 2. Surface segregation of comb polymers in polylactide. Biomacromolecules. 2:2001;545-556.
165. Koo L.Y., Irvine D.J., Mayes A.M., Lauffenburger D.A., Griffith L.G. Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. J Cell Sci. 115:2002;1423-1433.
166. Gronowicz G.A., Derome M.E. Synthetic peptide containing Arg-Gly Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones. J Bone Miner Res. 9:1994;193-201.
167. Burdick J.A., Anseth K.S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials. 23:2002;4315-4323.
168. Park K.H. Arg-Gly Asp (RGD) sequence conjugated in a synthetic copolymer bearing a sugar moiety for improved culture of parenchymal cells (hepatocytes). Biotechnol Lett. 24:2002;1401-1406.
169. Maheshwari G., Brown G., Lauffenburger D.A., Wells A., Griffith L.G. Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci. 113:2000;1677-1686.
170. Margel S., Vogler E.A., Firment L., Watt T., Haynie S., Sogah D.Y. Peptide, protein, and cellular interactions with self-assembled monolayer model surface. J Biomed Mater Res. 27:1993;1463-1476.
171. Delforge D., Gillon B., Art M., Dewelle J., Raes M., Remacle J. Design of a synthetic adhesion protein by grafting RGD tailed cyclic peptides on bovine serum albumin. Lett Pept Sci. 5:1998;87-91.
172. Bellahcène A., Bonjean K., Fohr B., Fedarko N.S., Robey F.A., Young M.F., Fisher L.W., Castronovo V. Bone sialprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res. 86:2000;885-891.
173. Jeschke B., Meyer J., Jonczyk A., Kessler H., Adamietz P., Meenen N.M., Kantlehner M., Goepfert C., Nies B. RGD-peptides for tissue engineering of articular cartilage. Biomaterials. 23:2002;3455-3463.
174. Chinn J.A., Sauter J.A., Phillips R.E. Jr., Kao W.J., Anderson J.M., Hanson S.R., Ashton T.R. Blood and tissue compatibility of modified polyester. thrombosis, inflammation, and healing J Biomed Mater Res. 39:1998;130-140.
175. Cui X., Lee V.A., Raphael Y., Wiler J.A., Hetke J.F., Anderson D.J., Martin D.C. Surface modification of neural recording electrodes with conducting polymer/biomolecule blends. J Biomed Mater Res. 56:2001;261-272.
176. Glass J., Blevitt J., Dickerson K., Pierschbacher M., Craig W.S. Cell attachment and motility on materials modified by surface-active RGD-containing peptides. Ann NY Acad Sci. 745:1994;177-186.
177. Barak L.S., Yocum R.R., Nothnagel E.A., Webb W.W. Fluorescence staining of the actin cytoskeleton in living cells with 7-nitrobenz-2-oxa-1,3-diazole-phallacidin. Proc Natl Acad Sci USA. 77:1980;980-984.
178. Montgomery A.M., Reisfeld R.A., Cheresh D.A. Integrin αvβ3 rescues melanoma cells from apoptosis in three- dimensional dermal collagen. Proc Natl Acad Sci USA. 91:1994;8856-8860.
179. Goodman S.L., Cooper S.L., Albrecht R.M. Integrin receptors and platelet adhesion to synthetic surfaces. J Biomed Mater Res. 27:1993;683-695.
180. Legler D.F., Wiedle G., Ross F.P., Imhof B.A. Superactivation of integrin αvβ3 by low antagonist concentrations. J Cell Sci. 114:2001;1545-1553.
181. Hautanen A., Gailit J., Mann D.M., Ruoslahti E. Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem. 264:1989;1437-1442.
182. Gumusderelioglu M., Turkoglu H. Biomodification of non-woven polyester fabrics by insulin and RGD for use in serum-free cultivation of tissue cells. Biomaterials. 23:2002;3927-3935.
183. Krijgsman B., Seifalian A.M., Salacinski H.J., Tai N.R., Punshon G., Fuller B.J., Hamilton G. An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea)urethane vascular conduit versus conventional biological coatings. its role in enhancing cellular retention Tissue Eng. 8:2002;673-680.
184. Tiwari A., Salacinski H.J., Punshon G., Hamilton G., Seifalian A.M. Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J. 16:2002;791-796.
185. Gobin A.S., West J.L. Cell migration through defined, synthetic ECM analogs. FASEB J. 16:2002;751-753.
186. Mann B.K., Gobin A.S., Tsai A.T., Schmedlen R.H., West J.L. Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains. synthetic ECM analogs for tissue engineering Biomaterials. 22:2001;3045-3051.
187. Mann B.K., West J.L. Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds. J Biomed Mater Res. 60:2002;86-93.
188. Schmedlen R.H., Masters K.S., West J.L. Photocrosslinkable polyvinyl alcohol hydrogels that can be modified with cell adhesion peptides for use in tissue engineering. Biomaterials. 23:2002;4325-4332.
189. Fujimoto K., Iwasaki C., Arai C., Kuwako M., Yasugi E. Control of cell death by the smart polymeric vehicle. Biomacromolecules. 1:2000;515-518.
190. Plant G.W., Woerly S., Harvey A.R. Hydrogels containing peptide or aminosugar sequences implanted into the rat brain. influence on cellular migration and axonal growth Exp Neurol. 143:1997;287-299.
191. Woerly S., Pinet E., de Robertis L., van Diep D., Bousmina M. Spinal cord repair with PHPMA hydrogel containing RGD peptides (NeuroGel). Biomaterials. 22:2001;1095-1111.
192. Loh N.K., Woerly S., Bunt S.M., Wilton S.D., Harvey A.R. The regrowth of axons within tissue defects in the CNS is promoted by implanted hydrogel matrices that contain BDNF and CNTF producing fibroblasts. Exp Neurol. 170:2001;72-84.
193. Kao W.J., Hubbell J.A., Anderson J.M. Protein-mediated macrophage adhesion and activation on biomaterials. a model for modulating cell behavior J Mater Sci: Mater Med. 10:1999;601-605.
194. Kao W.J., Lee D. In vivo modulation of host response and macrophage behavior by polymer networks grafted with fibronectin-derived biomimetic oligopeptides. the role of RGD and PHSRN domains Biomaterials. 22:2001;2901-2909.
195. Liu Y., Kao W.J. Human macrophage adhesion on fibronectin. The role of substratum and intracellular signalling kinases. Cell Signal. 14:2002;145-152.
196. Kao W.J., Lee D., Schense J.C., Hubbell J.A. Fibronectin modulates macrophage adhesion and FBGC formation. the role of RGD, PHSRN, and PRRARV domains J Biomed Mater Res. 55:2001;79-88.
197. Maynard H.D., Okada S.Y., Grubbs R.H. Inhibition of cell adhesion to fibronectin by oligopeptide-substituted polynorbornenes. J Am Chem Soc. 123:2001;1275-1279.
198. Sidouni F-.Z., Nurdin N., Chabrecek P., Lohmann D., Vogt J., Xanthopoulos N., Mathieu H.J., Francois P., Vaudaux P., Descouts P. Surface properties of a specifically modified high-grade medical polyurethane. Surf Sci. 491:2001;355-369.
199. Nicol A., Gowda D.C., Urry D.W. Cell adhesion and growth on synthetic elastomeric matrices containing Arg-Gly Asp-Ser. J Biomed Mater Res. 26:1992;393-413.
200. Anderheiden D., Klee D., Hocker H., Heller B., Kirkpatrick C.J., Mittermayer C. Surface modification of a biocompatible polymer based on polyurethane for artificial blood-vessels. J Mater Sci: Mater Med. 3:1992;1-4.
201. Belcheva N., Baldwin S.P., Saltzman W.M. Synthesis and characterization of polymer-(multi)-peptide conjugates for control of specific cell aggregation. J Biomater Sci Polym Ed. 9:1998;207-226.
202. Dai W.G., Saltzman W.M. Fibroblast aggregation by suspension with conjugates of poly(ethylene glycol) and RGD. Biotechnol Bioeng. 50:1996;349-356.
203. Hubbell J.A., Massia S.P., Desai N.P., Drumheller P.D. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Bio/Technology. 9:1991;568-572.
204. Massia S.P., Stark J. Immobilized RGD peptides on surface-grafted dextran promote biospecific cell attachment. J Biomed Mater Res. 56:2001;390-399.
205. Yanagi M., Kishida A., Shimotakahara T., Matsumoto H., Nishijima H., Akashi M., Aikou T. Experimental study of bioactive polyurethane sponge as an artificial trachea. ASAIO J. 40:1994;M412-418.
206. Matsuda T., Kondo A., Makino K., Akutsu T. Development of a novel artificial matrix with cell adhesion peptides for cell culture and artificial and hybrid organs. ASAIO Trans. 35:1989;677-679.
207. Rouhi AM. Biomaterials body shop: diverse approaches to diverse human needs. Chem Eng News 2000, 33-41.
208. Lin H-B, Lim F, Cooper SL. Polyurethanes containing covalently grafted RGD-peptides. In: Vincenzini P, editor. Materials in clinical applications. Faenza: Techna Srl; 1995. p. 385-92.
209. Holland J., Hersh L., Bryhan M., Onyiriuka E., Ziegler L. Culture of human vascular endothelial cells on an RGD-containing synthetic peptide attached to a starch-coated polystyrene surface. comparison with fibronectin-coated tissue grade polystyrene Biomaterials. 17:1996;2147-2156.
210. DeGiglio E., Sabbatini L., Colucci S., Zambonin G. Synthesis, analytical characterization, and osteoblast adhesion properties on RGD-grafted polypyrrole coatings on titanium substrates. J Biomat Sci Polym Ed. 11:2000;1073-1083.
211. Sank A., Rostami K., Weaver F., Ertl D., Yellin A., Nimni M., Tuan T.L. New evidence and new hope concerning endothelial seeding of vascular grafts. Am J Surg. 164:1992;199-204.
212. Eid K., Chen E., Griffith L., Glowacki J. Effect of RGD coating on osteocompatibility of PLGA-polymer disks in a rat tibial wound. J Biomed Mater Res. 57:2001;224-231.
213. Tweden K.S., Harasaki H., Jones M., Blevitt J.M., Craig W.S., Pierschbacher M., Helmus M.N. Accelerated healing of cardiovascular textiles promoted by an RGD peptide. J Heart Valve Dis. 4(Suppl. I):1995;S90-S97.
214. Halstenberg S., Panitch A., Rizzi S., Hall H., Hubbell J.A. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels. a cell adhesive and plasmin-degradable biosynthetic material for tissue repair Biomacromolecules. 3:2002;710-723.
215. Pierschbacher M.D., Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly Asp-Xaa on binding specificity in cell adhesion. J Biol Chem. 262:1987;17294-17298.
216. Goodman S.L., Hölzemann G., Sulyok G.A., Kessler H. Nanomolar small molecule inhibitors for αvβ6, αvβ5, and αvβ3 integrins. J Med Chem. 45:2002;1045-1051.
217. van der Pluijm G., Vloedgraven H.J., Ivanov B., Robey F.A., Grzesik W.J., Robey P.G., Papapoulos S.E., Lowik C.W. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res. 56:1996;1948-1955.
218. Kantlehner M., Finsinger D., Meyer J., Schaffner P., Jonczyk A., Diefenbach B., Nies B., Kessler H. Selective RGD-mediated adhesion of osteoblasts at surfaces of implants. Angew Chem Int Ed. 38:1999;560-562.
219. Hölzemann G. Merck KGaA Darmstadt, Germany. pc. 1999.
220. Xiao Y., Truskey G.A. Effect of receptor-ligand affinity on the strength of endothelial cell adhesion. Biophys J. 71:1996;2869-2884.
221. Cardarelli P.M., Yamagata S., Taguchi I., Gorcsan F., Chiang S.L., Lobl T. The collagen receptor α2β1, from MG-63 and HT1080 cells, interacts with a cyclic RGD peptide. J Biol Chem. 267:1992;23159-23164.
222. Genes N.G., Bonassar L.J. Regulation of chondrocyte adhesion to modified alginate surfaces. ASME Proc Bioeng Conf BED. 50:2001;631-632.
223. Dechantsreiter M.A., Planker E., Mathä B., Lohof E., Hölzemann G., Jonczyk A., Goodman S.L., Kessler H. N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists. J Med Chem. 42:1999;3033-3040.
224. Plow E.F., Pierschbacher M.D., Ruoslahti E., Marguerie G., Ginsberg M.H. Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets. Blood. 70:1987;110-115.
225. Pfaff M., Tangemann K., Muller B., Gurrath M., Muller G., Kessler H., Timpl R., Engel J. Selective recognition of cyclic RGD peptides of NMR defined conformation by αIIbβ3, αvβ3, and α5β1 integrins. J Biol Chem. 269:1994;20233-20238.
226. Cook G.A., Wilkinson D.A., Crossno J.T. Jr., Raghow R., Jennings L.K. The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin. Exp Cell Res. 251:1999;356-371.
227. Rezania A., Healy K.E. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res. 17:1999;615-623.
228. Ross F.P., Chappel J., Alvarez J.I., Sander D., Butler W.T., Farach-Carson M.C., Mintz K.A., Robey P.G., Teitelbaum S.L., Cheresh D.A. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone resorption. J Biol Chem. 268:1993;9901-9907.
229. Sinha R.K., Tuan R.S. Regulation of human osteoblast integrin expression by orthopedic implant materials. Bone. 18:1996;451-457.
230. Garcia A.J., Vega M.D., Boettiger D. Modulation of cell proliferation and differentiation through substrate- dependent changes in fibronectin conformation. Mol Biol Cell. 10:1999;785-798.
231. Singer I.I., Scott S., Kawka D.W., Kazazis D.M., Gailit J., Ruoslahti E. Cell surface distribution of fibronectin and vitronectin receptors depends on substrate composition and extracellular matrix accumulation. J Cell Biol. 106:1988;2171-2182.
232. Retta S.F., Cassara G., D'Amato M., Alessandro R., Pellegrino M., Degani S., De Leo G., Silengo L., Tarone G. Cross talk between αv integrins. β1 affects β3 mRNA stability Mol Biol Cell. 12:2001;3126-3138.
233. Simon K.O., Nutt E.M., Abraham D.G., Rodan G.A., Duong L.T. The αvβ3 integrin regulates α5β1-mediated cell migration toward fibronectin. J Biol Chem. 272:1997;29380-29389.
234. Singer I.I., Kawka D.W., Scott S., Mumford R.A., Lark M.W. The fibronectin cell attachment sequence Arg-Gly Asp-Ser promotes focal contact formation during early fibroblast attachment and spreading. J Cell Biol. 104:1987;573-584.
235. Mann B.K., Tsai A.T., Scott-Burden T., West J.L. Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. Biomaterials. 20:1999;2281-2286.
236. Rezania A., Healy K.E. The effect of peptide surface density on mineralization of a matrix deposited by osteogenic cells. J Biomed Mater Res. 52:2000;595-600.
237. Art M., Delforge D., Gillon B., Remacle J., Raes M. Synthesis of linear and cyclic RGD-peptides for the purpose of their chemical grafting on poorly adhesive polymers such as polyethylene terephthalate. Polym Preprints. 36:1995;115-116.
238. Kantlehner M, Dard M, Hersel U, Kessler H, Meyer J, Nies B, Sulyok G, Gibson C, Hölzemann G. Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II. In. DE Patent No. 10040103;2000.
239. Paniccia R., Colucci S., Grano M., Serra M., Zallone A.Z., Teti A. Immediate cell signal by bone-related peptides in human osteoclast-like cells. Am J Physiol. 265:1993;C1289-1297.
240. Olbrich K.C., Andersen T.T., Blumenstock F.A., Bizios R. Surfaces modified with covalently immobilized adhesive peptides affect fibroblast population motility. Biomaterials. 17:1996;759-764.
241. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science. 294:2001;1708-1712.
242. Geiger B. Encounters in Space. Science. 294:2001;1661-1663.
243. Hasenbein M.E., Andersen T.T., Bizios R. Micropatterned surfaces modified with select peptides promote exclusive interactions with osteoblasts. Biomaterials. 23:2002;3937-3942.
244. Boumrah D., Campbell M.M., Fenner S., Kinsman R.G. Spacer molecules in peptide sequences. incorporation into analogues of atrial natriuretc factor Tetrahedron. 53:1997;6977-6992.
245. Wong J.Y., Kuhl T.L., Israelachvili J.N., Mullah N., Zalipsky S. Direct measurement of a tethered ligand-receptor interaction potential. Science. 275:1997;820-822.
246. Lo C.M., Wang H.B., Dembo M., Wang Y.L. Cell movement is guided by the rigidity of the substrate. Biophys J. 79:2000;144-152.
247. Danilov Y.N., Juliano R.L. (Arg-Gly Asp)n-albumin conjugates as a model substratum for integrin-mediated cell adhesion. Exp Cell Res. 182:1989;186-196.
248. Service R.F. Tissue engineers build new bone. Science. 289:2000;1498-1500.
249. Massia S.P., Hubbell J.A. Covalent surface immobilization of Arg-Gly Asp- and Tyr-Ile-Gly Ser-Arg- containing peptides to obtain well-defined cell-adhesive substrates. Anal Biochem. 187:1990;292-301.
250. Sechler J.L., Cumiskey A.M., Gazzola D.M., Schwarzbauer J.E. A novel RGD-independent fibronectin assembly pathway initiated by α4β1 integrin binding to the alternatively spliced V region. J Cell Sci. 113:2000;1491-1498.
251. Irvine D.J., Hue K.A., Mayes A.M., Griffith L.G. Simulations of cell-surface integrin binding to nanoscale-clustered adhesion ligands. Biophys J. 82:2002;120-132.
252. Arnold M, Geierhaas C, Kantlehner M, Hersel U, Dahmen C, Kessler H, Eck W, Grunze M, Möller M, Spatz JP. Lateral control of integrin-receptor clustering by cell adhesion to nanostructured interfaces, in preparation.
253. Murata J., Saiki I., Ogawa R., Nishi N., Tokura S., Azuma I. Molecular-properties of poly(RGD) and its binding-capacities to metastatic melanoma-cells. Int J Pept Prot Res. 38:1991;212-217.
254. Monaghan S., Griffith-Johnson D., Matthews I., Bradley M. Solid-phase synthesis of peptide-dendrimer conjugates for an investigation of integrin binding. Arkivoc. 2:2001;U42-U49.
255. Griffith L.G., Lopina S. Microdistribution of substratum-bound ligands affects cell function. hepatocyte spreading on peo-tethered galactose Biomaterials. 19:1998;979-986.
256. Jeppesen C., Wong J.Y., Kuhl T.L., Israelachvili J.N., Mullah N., Zalipsky S., Marques C.M. Impact of polymer tether length on multiple ligand-receptor bond formation. Science. 293:2001;465-468.
257. Dekker F.J., Mol N.Jd., Ameijde Jv., Fischer M.J.E., Ruijtenbeek R., Redegeld F.A.M., Liskamp R.M.J. Replacement of the intervening amino acid sequence of a Syk-binding diphosphopeptide by a nonpeptide spacer with preservation of high affinity. ChemBioChem. 3:2002;238-242.
258. Stewart P.L., Chiu C.Y., Huang S., Muir T., Zhao Y., Chait B., Mathias P., Nemerow G.R. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. Embo J. 16:1997;1189-1198.
259. Stupack D.G., Li E., Silletti S.A., Kehler J.A., Geahlen R.L., Hahn K., Nemerow G.R., Cheresh D.A. Matrix valency regulates integrin-mediated lymphoid adhesion via Syk kinase. J Cell Biol. 144:1999;777-788.
260. Smilenov L.B., Mikhailov A., Pelham R.J., Marcantonio E.E., Gundersen G.G. Focal adhesion motility revealed in stationary fibroblasts. Science. 286:1999;1172-1174.
261. Small J.V., Kaverina I., Krylyshkina O., Rottner K. Cytoskeleton cross-talk during cell motility. FEBS Lett. 452:1999;96-99.
262. Beningo K.A., Dembo M., Kaverina I., Small J.V., Wang Y.L. Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts. J Cell Biol. 153:2001;881-888.
263. Sheetz M.P., Felsenfeld D., Galbraith C.G., Choquet D. Cell migration as a five-step cycle. Biochem Soc Symp. 65:1999;233-243.
264. DiMilla P.A., Stone J.A., Quinn J.A., Albelda S.M., Lauffenburger D.A. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol. 122:1993;729-737.
265. Palecek S.P., Loftus J.C., Ginsberg M.H., Lauffenburger D.A., Horwitz A.F. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature. 385:1997;537-540.
266. Holly S.P., Larson M.K., Parise L.V. Multiple roles of integrins in cell motility. Exp Cell Res. 261:2000;69-74.
267. Burgess B.T., Myles J.L., Dickinson R.B. Quantitative analysis of adhesion-mediated cell migration in three-dimensional gels of RGD-grafted collagen. Ann Biomed Eng. 28:2000;110-118.
268. Huttenlocher A., Ginsberg M.H., Horwitz A.F. Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol. 134:1996;1551-1562.
269. Giancotti F.G., Ruoslahti E. Elevated levels of the α5β1-fibronectin receptor suppress the transformed phenotype of Chinese Hamster Ovary Cells. Cell. 60:1990;849-859.
270. Slepian M.J., Massia S.P., Dehdashti B., Fritz A., Whitesell L. β3-integrins rather than β1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration. Circulation. 97:1998;1818-1827.
271. Clyman R.I., Mauray F., Kramer R.H. β1 and β3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res. 200:1992;272-284.
272. Gehlsen K.R., Davis G.E., Sriramarao P. Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis. 10:1992;111-120.
273. Felding-Habermann B., Fransvea E., O'Toole T.E., Manzuk L., Faha B., Hensler M. Involvement of tumor cell integrin αvβ3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastasis. 19:2002;427-436.
274. Reuning U. FrauenklinikTU München, Germany. pc. 2001.
275. Byzova T.V., Kim W., Midura R.J., Plow E.F. Activation of integrin αvβ3 regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res. 254:2000;299-308.
276. Liu G., Eskin S.G., Mikos A.G. Integrin αvβ3 is involved in stimulated migration of vascular adventitial fibroblasts by basic fibroblast growth factor but not platelet-derived growth factor. J Cell Biochem. 83:2001;129-135.
277. Yebra M., Parry G.C., Stromblad S., Mackman N., Rosenberg S., Mueller B.M., Cheresh D.A. Requirement of receptor-bound urokinase-type plasminogen activator for integrin αvβ5-directed cell migration. J Biol Chem. 271:1996;29393-29399.
278. Yan L., Moses M.A., Huang S., Ingber D.E. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. J Cell Sci. 113:2000;3979-3987.
279. Huang S., Ingber D.E. The structural and mechanical complexity of cell-growth control. Nat Cell Biol. 1:1999;E131-E138.
280. Rowley J.A., Mooney D.J. Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res. 60:2002;217-223.
281. Ingber D.E., Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis invitro. role of extracellular matrix J Cell Biol. 109:1989;317-330.
282. Myles J.L., Burgess B.T., Dickinson R.B. Modification of the adhesive properties of collagen by covalent grafting with RGD peptides. J Biomater Sci Polym Ed. 11:2000;69-86.
283. Cooper M.L., Hansbrough J.F., Foreman T.J. In vitro effects of matrix peptides on a cultured dermal-epidermal skin substitute. J Surg Res. 48:1990;528-533.
284. Grzesik J.J., Pierschbacher M.D., Amodeo M.F., Malaney T.I., Glass J.R. Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization. Biomaterials. 18:1997;1625-1632.
285. Schliephake H., Scharnweber D., Dard M., Rossler S., Sewing A., Meyer J., Hoogestraat D. Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest. An experimental pilot study in dogs. Clin Oral Implants Res. 13:2002;312-319.
286. Tamada Y. Modification of fibroin film with a chimera fibroin fragment for impovement of cell adhesion. Mat Res Soc Symp Proc (Biomaterials Regulating Cell Function and Tissue Development) 1998;530:27-32.
287. Schense J.C., Hubbell J.A. Three-dimensional migration of neurites is mediated by adhesion site density and affinity. J Biol Chem. 275:2000;6813-6818.
288. Schense J.C., Bloch J., Aebischer P., Hubbell J.A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat Biotechnol. 18:2000;415-419.
289. Schense J.C., Hubbell J.A. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug Chem. 10:1999;75-81.
290. Grzesik W.J., Ivanov B., Robey F.A., Southerland J., Yamauchi M. Synthetic integrin-binding peptides promote adhesion and proliferation of human periodontal ligament cells in vitro. J Dent Res. 77:1998;1606-1612.
291. Katagiri Y.U., Murakami M., Mori K., Iizuka J., Hara T., Tanaka K., Jia W.Y., Chambers A.F., Uede T. Non-RGD domains of osteopontin promote cell adhesion without involving αv integrins. J Cell Biochem. 62:1996;123-131.
292. Streeter H.B., Rees D.A. Fibroblast adhesion to RGDS shows novel features compared with fibronectin. J Cell Biol. 105:1987;507-515.
293. Patel N., Bhandari R., Shakesheff K.M., Cannizzaro S.M., Davies M.C., Langer R., Roberts C.J., Tendler S.J.B., Williams P.M. Printing patterns of biospecifically adsorbed protein. J Biomat Sci Polym Ed. 11:2000;319-331.
294. McDevitt T.C., Nelson K.E., Stayton P.S. Constrained cell recognition peptides engineered into streptavidin. Biotechnol Progr. 15:1999;391-396.
295. Cannizzaro S.M., Padera R.F., Langer R., Rogers R.A., Black F.E., Davies M.C., Tendler S.J., Shakesheff K.M. A novel biotinylated degradable polymer for cell-interactive applications. Biotechnol Bioeng. 58:1998;529-535.
296. Mertz P.M., Davis S.C., Franzen L., Uchima F.D., Pickett M.P., Pierschbacher M.D., Polarek J.W. Effects of an arginine-glycine-aspartic acid peptide-containing artificial matrix on epithelial migration in vitro and experimental second-degree burn wound healing in vivo. J Burn Care Rehabil. 17:1996;199-206.
297. Marchi-Artzner V., Lorz B., Hellerer U., Kantlehner M., Kessler H., Sackmann E. Selective adhesion of endothelial cells to artificial membranes with a synthetic RGD-lipopeptide. Chem Eur J. 7:2001;1095-1101.
298. Glass J.R., Dickerson K.T., Stecker K., Polarek J.W. Characterization of a hyaluronic acid-Arg-Gly Asp peptide cell attachment matrix. Biomaterials. 17:1996;1101-1108.
299. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials. 20:1999;45-53.
300. Marler J.J., Guha A., Rowley J., Koka R., Mooney D., Upton J., Vacanti J.P. Soft-tissue augmentation with injectable alginate and syngeneic fibroblasts. Plast Reconstr Surg. 105:2000;2049-2058.
301. Halberstadt C., Austin C., Rowley J., Culberson C., Loebsack A., Wyatt S., Coleman S., Blacksten L., Burg K., Mooney D., Holder W. Jr. A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep. Tissue Eng. 8:2002;309-319.
302. Alsberg E., Anderson K.W., Albeiruti A., Rowley J.A., Mooney D.J. Engineering growing tissues. Proc Natl Acad Sci USA. 99:2002;12025-12030.
303. Alsberg E., Anderson K.W., Albeiruti A., Franceschi R.T., Mooney D.J. Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res. 80:2001;2025-2029.
304. Rowley J.A., Sun Z.X., Goldman D., Mooney D.J. Biomaterials to spatially regulate cell fate. Adv Mat. 14:2002;886-889.
305. Onyiriuka E. Modification of polystyrene cell culture surfaces by grafting a thin film of starch. J Adhes Sci Technol. 10:1996;617-633.
306. Massia S.P., Stark J., Letbetter D.S. Surface-immobilized dextran limits cell adhesion and spreading. Biomaterials. 21:2000;2253-2261.
307. Besselink G.A., Beugeling T., Poot A.A., Van Aken W.G., Bantjes A. Preparation of cell-affinity adsorbents by immobilization of peptides to Sephadex G-10. J Biomat Sci Polym Ed. 6:1994;675-693.
308. Rubin B.G., McGraw D.J., Sicard G.A., Santoro S.A. New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts. J Vasc Surg. 15:1992;683-692.
309. Wierzba A., Reichl U., Turner R.F.B., Warren R.A.J., Kilburn D.G. Adhesion of mammalian-cells to a recombinant attachment factor, CBD/RGD, analyzed by image-analysis. Biotechnol Bioeng. 46:1995;185-193.
310. Wierzba A., Reichl U., Turner R.F.B., Warren R.A.J., Kilburn D.G. Production and properties of a bifunctional fusion protein that mediates attachment of vero cells to cellulosic matrices. Biotechnol Bioeng. 47:1995;147-154.
311. Chu W-.P., Hsu S-.H., Chen D.C. Application of the CBD-RGD peptide in biomaterial for tissue repair I. Use of CBD-RGD on polyurethane. Xingda Goncheng Xueabo. 11:2000;39-51.
312. Chu W-.P., Hsu S-.H., Chen D.C. Application of the CBD-RGD peptide in biomaterial for tissue repair I, cell adhesion onto different materials coated with CBD-RGD and the comparison with plasma treatment. Xingda Goncheng Xueabo. 11:2000;53-65.
313. Janssen M.I., van Leeuwen M.B.M., Scholtmeijerc K., van Kooten T.G., Dijkhuizena L., Wösten H.A.B. Coating with genetic engineered hydrophobin promotes growth of fibroblasts on a hydrophobic solid. Biomaterials. 23:2002;4847-4854.
314. Stedronsky ER, Cappello J, David S, Donofrio DM, McArthur T, McGrath K, Panaro MA, Putnam D, Spencer W, Wallis O. Injection molding of ProNectin F dispersed in polystyrene for the fabrication of plastic ware activated towards attachment of mammalian cells. Mater Res Soc Symp Proc (Biomolecular Materials by Design) 1994;330:157-64.
315. Burridge K., Turner C.E., Romer L.H. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix. a role in cytoskeletal assembly J Cell Biol. 119:1992;893-903.
316. Bhadriraju K., Hansen L.K. Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins. Biomaterials. 21:2000;267-272.
317. Neidlinger-Wilke C., Grood E.S., Wang J-.C., Brand R.A., Claes L. Cell alignment is induced by cyclic changes in cell length. studies of cells grown in cyclically stretched substrates J Orthop Res. 19:2001;286-293.
318. Putnam D., Cappello J. Improving the growth of anchorage-dependent cells upon abrupt passage to serum-free media. Am Biotechnol Lab. 11:1993;14-16.
319. Tschopp J.F., Cahn F., Pierschbacher M. RGD-enhanced Integra artificial skin. Polym Prep. 39:1998;255.
320. Rezania A., Healy K.E. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol Prog. 15:1999;19-32.
321. Dee K.C., Anderson T.T., Bizios R. Osteoblast population migration characteristics on substrates modified with immobilized adhesive peptides. Biomaterials. 20:1999;221-227.
322. Dee K.C., Rueger D.C., Andersen T.T., Bizios R. Conditions which promote mineralization at the bone-implant interface. a model in vitro study Biomaterials. 17:1996;209-215.
323. Rezania A., Johnson R., Lefkow A.R., Healy K.E. Bioactivation of metal oxide surfaces. 1 Surface characterization and cell response. Langmuir. 15:1999;6931-6939.
324. Dahmen C, Janotta A, Dimova-Malinovska D, Marx S, Jeschke B, Nies B, Kessler H, Stutzmann M. Surface functionalization of amorphous silicon and silicon suboxides for biological applications. Thin Solid Films 2002, accepted for application.
325. Saneinejad S., Shoichet M.S. Patterned glass surfaces direct cell adhesion and process outgrowth of primary neurons of the central nervous system. J Biomed Mater Res. 42:1998;13-19.
326. Ferris D.M., Moodie G.D., Dimond P.M., Gioranni C.W., Ehrlich M.G., Valentini R.F. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials. 20:1999;2323-2331.
327. Yeo W.S., Hodneland C.D., Mrksich M. Electroactive monolayer substrates that selectively release adherent cells. Chembiochem. 2:2001;590-593.
328. Moodie GD, Ferris DM, Hertzog BA, Wimmer N, Morgan H, Chen CY, Mathiowitz E, Valentini RF. Early osteoblast attachment, spreading, and focal adhesions on RGD coated surface. Mat Res Soc Symp Proc (Biomedical materials-drug delivery, implants and tissue engineering) 1999;550:207-14.
329. Chaikof EL, Wang HS, Winger TM, Stephens S, Dluhy RA. Self-assembling peptide monolayers: endothelial cell behavior on functionalized metal substrates. In: Thin Films and Surfaces for Bioactivity and Biomedical Application, vol. 414, 1996. p. 17-22.
330. Roberts C., Chen C.S., Mrksich M., Martichonok V., Ingber D.E., Whitesides G.M. Using mixed self-assembled monolayers presenting RGD and (EG)3OH groups to characterize long-term attachment of bovine capillary endothelial cells to surface. J Am Chem Soc. 120:1998;6548-6555.
331. Fujisawa R., Mizuno M., Nodasaka Y., Kuboki Y. Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (Glu7-Pro-Arg-Gly Asp-Thr) containing two functional sequences of bone sialoprotein. Matrix Biol. 16:1997;21-28.
332. Itoh D., Yoneda S., Kuroda S., Kondo H., Umezawa A., Ohya K., Ohyama T., Kasugai S. Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (EEEEEEEPRGDT) in vitro. J Biomed Mater Res. 62:2002;292-298.
333. Hersel U., Kantlehner M., Dahmen C., Jeschke B., Meyer J., Jonczyk A., Adamietz P., Meenen N., Kessler H. Cyclische RGD-Peptide zur Stimulierung der Zelladhäsion auf Biomaterialien. Biomaterialien. 2:2001;108.
334. Gilbert M., Shaw W.J., Long J.R., Nelson K., Drobny G.P., Giachelli C.M., Stayton P.S. Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion. J Biomol Chem. 275:2000;16213-16218.
335. Aucoin L., Griffith C.M., Pleizier G., Deslandes Y., Sheardown H. Interactions of corneal epithelial cells and surfaces modified with cell adhesion peptide combinations. J Biomater Sci Polym Ed. 13:2002;447-462.
336. Williams E., Williams G., Gour B.J., Blaschuk O.W., Doherty P. A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif. J Biol Chem. 275:2000;4007-4012.
337. Isacke C.M., Horton M.A. The adhesion molecules fact book. 2000;Academic Press, London.
338. Wong J.Y., Weng Z., Moll S., Kim S., Brown C.T. Identification and validation of a novel cell-recognition site (KNEED) on the 8th type III domain of fibronectin. Biomaterials. 23:2002;3865-3870.
339. Maeshima Y., Yerramalla U.L., Dhanabal M., Holthaus K.A., Barbashov S., Kharbanda S., Reimer C., Manfredi M., Dickerson W.M., Kalluri R. Extracellular matrix-derived peptide binds to αvβ3 integrin and inhibits angiogenesis. J Biol Chem. 276:2001;31959-31968.
340. Koivunen E., Wang B., Ruoslahti E. Isolation of a highly specific ligand for the α5β1 integrin from a phage display library. J Cell Biol. 124:1994;373-380.
341. Kao W.Y.J., Liu Y.P., Gundloori R., Li J., Lee D., Einerson N., Burmania J., Stevens K. Engineering endogenous inflammatory cells as delivery vehicles. J Control Release. 78:2002;219-233.
342. Altroff H., van der Walle C.F., Asselin J., Fairless R., Campbell I.D., Mardon H.J. The eighth FIII domain of human fibronectin promotes integrin α5β1 binding via stabilization of the ninth FIII domain. J Biol Chem. 276:2001;38885-38892.
343. Aota S., Nomizu M., Yamada K.M. The Short Amino-Acid-Sequence Pro-His-Ser-Arg-Asn in Human Fibronectin Enhances Cell-Adhesive Function. J Biol Chem. 269:1994;24756-24761.
344. Gailit J., Pierschbacher M., Clark R.A. Expression of functional α4β1 integrin by human dermal fibroblasts. J Invest Dermatol. 100:1993;323-328.
345. Humphries M.J., Akiyama S.K., Komoriya A., Olden K., Yamada K.M. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J Cell Biol. 103:1986;2637-2647.
346. Lander A.D. Understanding the molecules of neural cell contacts. emerging patterns of structure and function Trends Neurosci. 12:1989;189-195.
347. Graf J., Ogle R.C., Robey F.A., Sasaki M., Martin G.R., Yamada Y., Kleinman H.K. A pentapeptide from the laminin-B1 chain mediates cell-adhesion and binds the 67000-laminin receptor. Biochemistry. 26:1987;6896-6900.
348. Hinek A. Biological roles of the non-integrin elastin/laminin receptor. Biol Chem. 377:1996;471-480.
349. Massia S.P., Rao S.S., Hubbell J.A. Covalently immobilized laminin peptide Tyr-Ile-Gly Ser-Arg (YIGSR) supports cell spreading and colocalization of the 67-kilodalton laminin receptor with α-actinin and vinculin. J Biol Chem. 268:1993;8053-8059.
350. Borkenhagen M., Clemence J.F., Sigrist H., Aebischer P. Three-dimensional extracellular matrix engineering in the nervous system. J Biomed Mater Res. 40:1998;392-400.
351. Maeda T., Titani K., Sekiguchi K. Cell-adhesive activity and receptor-binding specificity of the laminin-derived YIGSR sequence grafted onto staphylococcal protein-A. J Biochem. 115:1994;182-189.
352. Huber M., Heiduschka P., Kienle S., Pavlidis C., Mack J., Walk T., Jung G., Thanos S. Modification of glassy carbon surfaces with synthetic laminin-derived peptides for nerve cell attachment and neurite growth. J Biomed Mater Res. 41:1998;278-288.
353. Ranieri J.P., Bellamkonda R., Bekos E.J., Vargo T.G., Gardella J.A., Aebischer P. Neuronal cell attachment to fluorinated ethylene-propylene films with covalently immobilized laminin oligopeptides YIGSR and IKVAV. J Biomed Mater Res. 29:1995;779-785.
354. Ranieri J.P., Bellamkonda R., Bekos E.J., Gardella J.A., Mathieu H.J.,
355. Cardin A.D., Weintraub H.J.R. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis. 9:1989;21-32.
356. Prime K.L., Whitesides G.M. Adsorption of proteins onto surfaces containing end-attached oligo(ethylene oxid). a model system using self-assembled monolayers J Am Chem Soc. 115:1993;10714-10721.
357. Woods A., McCarthy J.B., Furcht L.T., Couchman J.R. A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell. 4:1993;605-613.
358. Huebsch J.B., Fields G.B., Triebes T.G., Mooradian D.L. Photoreactive analog of peptide FN-C/H-V from the carboxy-terminal heparin-binding domains of fibronectin supports endothelial cell adhesion and spreading on biomaterial surfaces. J Biomed Mater Res. 31:1996;555-567.
359. Dee K.C., Andersen T.T., Bizios R. Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials. J Biomed Mater Res. 40:1998;371-377.
360. Massia S.P., Hubbell J.A. Immobilized amines and basic amino acids as mimetic heparin-binding domains for cell surface proteoglycan-mediated adhesion. J Biol Chem. 267:1992;10133-10141.
361. Sottile J., Hocking D.C., Langenbach K.J. Fibronectin polymerization stimulates cell growth by RGD-dependent and -independent mechanisms. J Cell Sci. 113:2000;4287-4299.
362. Woods A., Couchman J.R. Syndecan-4 and focal adhesion function. Curr Opin Cell Biol. 13:2001;578-583.
363. Vogel B.E., Lee S.J., Hildebrand A., Craig W., Pierschbacher M.D., Wongstaal F., Ruoslahti E. A novel integrin specificity exemplified by binding of the αvβ5 integrin to the basic domain of the HIV tat protein and vitronectin. J Cell Biol. 121:1993;461-468.
364. Weisz O.A., Schnaar R.L. Hepatocyte adhesion to carbohydrate-derivatized surfaces. II. Regulation of cytoskeletal organization and cell morphology. J Cell Biol. 115:1991;495-504.
365. Kim S.H., Goto M., Akaike T. Specific binding of glucose-derivatized polymers to the asialoglycoprotein receptor of mouse primary hepatocytes. J Biol Chem. 276:2001;35312-35319.
366. Chevolot Y., Martins J., Milosevic N., Leonard D., Zeng S., Malissard M., Berger E.G., Maier P., Mathieu H.J., Crout D.H., Sigrist H. Immobilisation on polystyrene of diazirine derivatives of mono- and disaccharides. biological activities of modified surfaces Bioorg Med Chem. 9:2001;2943-2953.
367. Yang J., Goto M., Ise H., Cho C.S., Akaike T. Galactosylated alginate as a scaffold for hepatocytes entrapment. Biomaterials. 23:2002;471-479.
368. Yoon J.J., Nam Y.S., Kim J.H., Park T.G. Surface immobilization of galactose onto aliphatic biodegradable polymers for hepatocyte culture. Biotechnol Bioeng. 78:2002;1-10.
369. Kiessling L.L., Gestwicki J.E., Strong L.E. Synthetic multivalent ligands in the exploration of cell-surface interactions. Curr Opin Chem Biol. 4:2000;696-703.
370. Kiessling L.L., Pohl N.L. Strength in numbers. non-natural polyvalent carbohydrate derivatives Chem Biol. 3:1996;71-77.
371. Delforge D., Art M., Gillon B., Dieu M., Delaive E., Raes M., Remacle J. Automated solid-phase synthesis of cyclic peptides bearing a side-chain tail designed for subsequent chemical grafting. Anal Biochem. 242:1996;180-186.
372. Scott E.S., Wiseman J.W., Evans M.J., Colledge W.H. Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J Gene Med. 3:2001;125-134.